Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
4.600
-0.320 (-6.50%)
At close: May 28, 2025, 4:00 PM
4.550
-0.050 (-1.09%)
After-hours: May 28, 2025, 5:57 PM EDT
Aptevo Therapeutics Market Cap
Aptevo Therapeutics has a market cap or net worth of $3.11 million as of May 28, 2025. Its market cap has decreased by -18.07% in one year.
Market Cap
3.11M
Enterprise Value
5.19M
1-Year Change
-18.07%
Ranking
Category
Stock Price
$4.60
Market Cap Chart
Since July 20, 2016, Aptevo Therapeutics's market cap has decreased from $160.50M to $3.11M, a decrease of -98.06%. That is a compound annual growth rate of -35.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2025 | 2.00M | -9.09% |
| Dec 31, 2024 | 2.20M | -31.25% |
| Dec 29, 2023 | 3.20M | -72.88% |
| Dec 30, 2022 | 11.80M | -69.27% |
| Dec 31, 2021 | 38.40M | -74.67% |
| Dec 31, 2020 | 151.60M | 413.90% |
| Dec 31, 2019 | 29.50M | 2.08% |
| Dec 31, 2018 | 28.90M | -68.17% |
| Dec 29, 2017 | 90.80M | 85.69% |
| Dec 30, 2016 | 48.90M | -69.53% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 651.06B |
| Johnson & Johnson | 368.73B |
| AbbVie | 328.06B |
| Novo Nordisk | 313.75B |
| UnitedHealth Group | 267.61B |
| Abbott Laboratories | 231.29B |
| Novartis AG | 221.98B |
| AstraZeneca | 219.74B |